Click image to enlarge
Medex Healthcare Research is conducting a research study of an investigational cream which contains a low concentration of cooper for the treatment of chronic pain caused by post-herpetic neuralgia. The study entails 4 visits over 30 days.
Qualified Participants Must:
Have a diagnosis of post-herpetic neuralgia for more than 3 months
Have persistent pain for more than 6 months from the appearance of herpes zoster rash that is not located above the scalp hairline, or in immediate proximity to mucous membranes
Be 18 years of age or older
Qualified Participants May Receive:
Study participants will receive all study related care at no charge, including physical examinations, lab services, and study medication. Qualified participants will also receive compensation for their time and travel.